More Than 100 Seniors Died After Receiving This Flu Shot Given By Pharmacies | AltHealthWorks.com
In the second study 15,992 adults ages 65 and older received the Fluzone high-dose and 15,991 received the regular Fluzone. Results show that 1,323 high-dose and 1,442 regular Fluzone recipients had a SAE within 6 to 8 months post-vaccination (204 high-dose and 200 regular-dose experienced a SAE within 30 days). In addition, 83 high-dose and 84 regular-dose died within 6 to 8 months, and 6 high-dose recipients died within 30 days post-vaccination.
According to the Fluzone vaccine information sheet none of these deaths were linked to the vaccine. They state that “these data do not provide evidence for a causal relationship between deaths and vaccination with Fluzone High-Dose.”
The first study claims the deaths cannot be linked to the clinical study because “the majority of these participants had a medical history of cardiac, hepatic, neoplastic, renal, and/or respiratory diseases.” The second study claims the same due to the majority of participants having “one or more chronic comorbid illnesses.”
The question arises – without further investigating, how did they arrive at the conclusion that none of the deaths were connected to the vaccination? Why wasn’t the data between seniors with existing conditions and without existing conditions ever compared or added to the package insert? And can we trust the word of the pharmaceutical company who sponsored its own study?
At any rate, 105 deaths and the sheer amount of adverse effects recorded between the two studies are serious red flags for anyone considering a flu shot. Serious adverse events include life-threatening issues like Guillain-Barré Syndrome, which has symptoms similar to polio including paralysis.
Perhaps, that is one of the reasons why when receiving the vaccine, the patient needs to sign a consent form first